Institute for Social Research, Survey Research Center, University of Michigan, 426 Thompson St., Ann Arbor, 48104, MI, USA.
Department of Epidemiology, School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, 48109, MI, USA.
Int J Biometeorol. 2024 Oct;68(10):2143-2152. doi: 10.1007/s00484-024-02737-y. Epub 2024 Aug 14.
Allergic rhino-conjunctivitis (AR) is a globally relevant health disorder characterized by sneezing, rhinorrhea and sleep disturbance. Ragweed (Ambrosia artemisiifolia) is a plant common to North America and an important allergen. Coarse methods of measuring airborne pollen counts are used to predict seasonal allergy symptoms. This research used a longitudinal study design with a novel, model-based raster of predicted pollen counts to test associations with self-reported symptoms of AR collected from patients receiving immunotherapy for pollen allergies at an allergy clinic. Researchers visited a clinic six times over three weeks. Immunotherapy patients were asked to fill out a brief intake survey on allergic and symptomatic profiles, daytime sleepiness, housing quality, and demographics. Participants responded to a daily, emailed survey on sleepiness and asthma symptoms for 21 days. Using the date and location of responses, ragweed pollen counts were extracted from a prognostic, model based raster (25km pixels). Lag associations of pollen counts with sleepiness were tested using a logistic regression model , adjusted for housing and demographic characteristics, in a distributed lag non-linear model (DLNM) framework. 49 people participated in the study. 26 (52%) were female. The mean age was 37.9 years. Asthma/allergy symptoms were not associated with ragweed pollen but sleepiness was highest two days after exposure (Estimate: 0.33 [0.04,0.62]). Subjects traveled widely during the study period. Intense exposures to ragweed pollen may be associated with daytime sleepiness within small exposure windows. Model-based predicted pollen counts could be used to study health impacts of pollen in people with disease severe enough to receive immunotherapy. Daytime sleepiness can affect productivity and injury risk, and pollen season length and allergenicity may be increasing with climate change. Thus our results may have important implications for population health.
变应性鼻结膜炎(AR)是一种具有全球相关性的健康障碍,其特征为打喷嚏、流涕和睡眠障碍。豚草(Ambrosia artemisiifolia)是一种常见于北美的植物,也是一种重要的过敏原。测量空气中花粉计数的粗略方法用于预测季节性过敏症状。本研究采用纵向研究设计,使用新型基于模型的预测花粉计数栅格来测试与在过敏诊所接受花粉过敏免疫治疗的患者报告的 AR 症状之间的关联。研究人员在三周内六次访问诊所。免疫治疗患者被要求填写一份关于过敏和症状特征、白天嗜睡、住房质量和人口统计学的简短摄入调查。参与者在 21 天内每天通过电子邮件回复睡眠和哮喘症状的调查。根据回答的日期和地点,从预测性基于模型的栅格(25km 像素)中提取豚草花粉计数。使用逻辑回归模型,在分布式滞后非线性模型(DLNM)框架中,调整住房和人口统计学特征,测试花粉计数与嗜睡之间的滞后关联。49 人参与了这项研究。26 人(52%)为女性。平均年龄为 37.9 岁。哮喘/过敏症状与豚草花粉无关,但暴露后两天嗜睡程度最高(估计值:0.33[0.04,0.62])。研究期间,参与者广泛旅行。在小的暴露窗口内,强烈暴露于豚草花粉可能与白天嗜睡有关。基于模型的预测花粉计数可用于研究疾病严重程度足以接受免疫治疗的人群中花粉对健康的影响。白天嗜睡会影响生产力和受伤风险,花粉季节长度和变应原性可能随着气候变化而增加。因此,我们的研究结果可能对人群健康具有重要意义。